Prothrombin as Co-Factor of the Circulating Anticoagulant in Systemic Lupus Erythematosus?

A Loeliger; E. J. J Alsbach; with the technical assistance of Miss

doi:10.1055/s-0038-1654385

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 1959; 03(02): 237-256
DOI: 10.1055/s-0038-1654385

Originalarbeiten — Original Articles — Travaux Originaux

Schattauer GmbH

Prothrombin as Co-Factor of the Circulating Anticoagulant in Systemic Lupus Erythematosus?

Authors

A Loeliger

¹Clinic for Internal Medicine (Director: Prof. J. Mulder), University Hospital, Leyden, Holland

with the technical assistance of Miss

E. J. J Alsbach

¹Clinic for Internal Medicine (Director: Prof. J. Mulder), University Hospital, Leyden, Holland

References
1 Barkhan P. Observations on a coagulation defect characterised by thrombocytopenia with a circulating anticoagulant. S. Afr. J. med. Sci 1952; 17: 87
2 Biggs R, Macfarlane R. G. Human blood coagulation and its disorders. Black-well Scientific Publ; Oxford: 1957
3 Bonnin J. A, Cohen A. K, Hicks N. D. Coagulation defects in a case of systemic lupus erythematosus with thrombocytopenia. Brit. J. Haematol 1956; 2: 168
4 Conley C. L, Hartmann R. C. A hemorrhagic disorder caused by circulating anticoagulant in patients with disseminated lupus erytematosus. J. clin. Invest 1952; 31: 621
5 Dameshek W. Systemic lupus erythematosus: A complex auto-immune disorder? Ann. internat. Med 1958; 48: 707
6 AAAAAFrick P. G. Acquired circulating anticoagulants in systematic “collagen disease”. Blood 1955; 10: 691
7 Hartert H. Klinische Blutgerinnungsstudien mit der Thrombelastographie. Dtsch. Arch. klin. Med 1952; 199: 284 (293, 402, 414)
8 van Herwerden M. A. Een eenvoudige telmethode voor bloedplaatjes. Ned. T. Geneesk 1915; 11: 1866
9 Hicks N. D, Pitney W. R. A rapid screening test for disorders of thromboplastin generation. Brit. J. Haematol 1957; 3: 227
10 Hitzig W. H, Labhart A, Uehlinger E. Transitorische Hemmkörperhämo-philie bei Rheumatismus. Helv. med. Acta 1951; 18: 410
11 Kovács E. Steigerung der endogenen Antithrombokinase-Produktion bei Lungenembolie und Myokardinfarkt. Thromb. Diath. haem 1957; 1: 541
12 Laurell A. B, Nilsson I. M. Hypergammaglobulinemia, circulating anticoagulant, and biologic false positive Wassermann reaction. J. Lab. clin. Med 1957; 49: 694
13 Lee S. L. Laboratory studies in systemic lupus erythematosus. AMA Arch. Dermat 1956; 73: 313
14 Lee S. L, Sanders M. A disorder of blood coagulation in systemic lupus erythematosus. J. clin. Invest 1955; 34: 1814
15 Ley A. B, Reader G. G, Sorenson C. W, Overman R. S. Idiopathic hypoprothrombinemia associated with hemorrhagic diathesis and the effect of vitamin K. Blood 1951; 6: 740
16 Loeliger A. Über den Nachweis eines neuen Blutgerinnungsfaktors: Faktor VIL Wien. Z. inn. Med 1952; 33: 169
17 Loe liger A, Hers J. F. Ph. Chronic Antithrombinaemia (Antithrombin V) with haemorrhagic diathesis in a case of rheumatoid arthritis with hypergammaglobulinaemia. Thromb. Diath. haem 1957; 1: 499
18 Mueller J. F, Ratnoff O, Heinle R. W. Observations on the characteristics on an unusual circulating anticoagulant. J. Lab. clin. Med 1951; 38: 254
19 Owren P. A, Aas K. The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin. Scand. J. clin. Lab. Invest 1951; 3: 201
20 vanderPol E. T, Kettenborg H. K, de Vries S. L. Een modificatie van de “thrombin generation test”. Ned. T. Geneesk 1956; 100: 1900
21 Post C. R, den Ottolander G. J. H, Hoorweg P. G. Een familiale vorm van idiopathische hypoprothrombinaemie. Ned. T. Geneesk 1956; 100: 1981
22 Quick A. J. Hemorrhagic diseases. Lea & Febiger; Philadelphia: 1957
23 Ramot C, Singer K. An unusual circulating anticoagulant in systemic lupus erythematosus. Acta haemat. (Basel) 1956; 16: 158
24 Seligmann M. Etudes immunologiques sur le lupus érythémateux disséminé. Rev. Franç. d’Etud. Clin. et Biol 1958; 3: 558
25 Seligmann M, Milgrom F, Trefouel J. Mise en évidence par la fixation du complément de la réaction entre acide désoxyribonucléique et sérum de malades atteints de lupus érythémateux disséminé. C. R. Acad. Sci. (Paris) 1958; 245: 1472
26 Swift S. A serum anticoagulant factor in systemic lupus erythematosus. AMA Arch. Dermat 1956; 74: 296
27 Verstraete M, Vandenbroucke J. Occurence and mode of action of endogenous circulating anticoagulant. J. Lab, clin. Med 1956; 48: 673